Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 7850708, 6 pages
https://doi.org/10.1155/2017/7850708
Review Article

Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence

1Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
2Institut Curie, PSL Research University, CNRS, UMR 144, 75005 Paris, France
3Université Paris Sud, Université Paris-Saclay, CNRS, UMR 144, 91405 Orsay, France
4Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Correspondence should be addressed to Xiang-Yu Meng

Received 7 February 2017; Accepted 30 April 2017; Published 5 June 2017

Academic Editor: Paola Gazzaniga

Copyright © 2017 Xiang-Yu Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. Cumberbatch, M. Rota, J. W. Catto, and C. La Vecchia, “The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks,” European Urology, vol. 70, no. 3, pp. 458–466, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rota, C. Bosetti, S. Boccia, P. Boffetta, and C. La Vecchia, “Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: an updated systematic review and a meta-analysis to 2014,” Archives of Toxicology, vol. 88, no. 8, pp. 1479–1490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Kiemeney, P. Sulem, S. Besenbacher et al., “A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 42, no. 5, pp. 415–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Kiemeney, S. Thorlacius, P. Sulem et al., “Sequence variant on 8q24 confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 40, no. 11, pp. 1307–1312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Rafnar, P. Sulem, S. N. Stacey et al., “Sequence variants at the TERT-CLPTM1L locus associate with many cancer types,” Nature Genetics, vol. 41, no. 2, pp. 221–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Wu, Y. Ye, L. A. Kiemeney et al., “Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 41, no. 9, pp. 991–995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Cappellen, C. De Oliveira, D. Ricol et al., “Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas,” Nature Genetics, vol. 23, no. 1, pp. 18–20, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. S. V. Williams, C. D. Hurst, and M. A. Knowles, “Oncogenic FGFR3 gene fusions in bladder cancer,” Human Molecular Genetics, vol. 22, no. 4, pp. 795–803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Wang, W. Zhang, L. Yuan, G. Fu, Q. Wei, and Z. Zhang, “Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population,” Carcinogenesis, vol. 30, no. 6, pp. 991–996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Google Scholar
  13. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Egger, G. Davey Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” BMJ, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar
  16. J. D. Figueroa, S. Koutros, J. S. Colt et al., “Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms,” Journal of the National Cancer Institute, vol. 107, no. 11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Ma, Q. Hu, Z. Chen et al., “Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population,” Molecular Carcinogenesis, vol. 52, no. 11, pp. 916–921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Qiao, R. Wang, W. Xie, Y. Sun, C. Wu, and H. Hu, “Association between polymorphism of rs798766 and urothelial bladder cancer risk from Han population of Tianjin,” Journal of Tianjin Medical University, vol. 21, no. 3, pp. 208–211, 2015. View at Google Scholar
  19. M. Wang, H. Chu, Q. Lv et al., “Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer,” International Journal of Cancer, vol. 135, no. 11, pp. 2653–2660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Wang, H. Chu, F. Yan et al., “Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population,” Carcinogenesis, vol. 32, no. 6, pp. 872–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Wang, D. Ye, J. Guo et al., “Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer,” Genes, Chromosomes & Cancer, vol. 53, no. 1, pp. 98–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Yates, M. Roupret, S. J. Drouin et al., “Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours,” World Journal of Urology, vol. 31, no. 1, pp. 53–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Cantiello, A. Cicione, A. Salonia et al., “Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review,” International Journal of Urology, vol. 22, no. 1, pp. 22–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Keimling, G. Behrens, D. Schmid, C. Jochem, and M. F. Leitzmann, “The association between physical activity and bladder cancer: systematic review and meta-analysis,” British Journal of Cancer, vol. 110, no. 7, pp. 1862–1870, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Malats and F. X. Real, “Epidemiology of bladder cancer,” Hematology/Oncology Clinics of North America, vol. 29, no. 2, pp. 177–189, 2015, vii. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Xu, X. T. Zeng, T. Z. Liu et al., “Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies,” Medicine (Baltimore), vol. 94, no. 17, article e759, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Peset and I. Vernos, “The TACC proteins: TACC-ling microtubule dynamics and centrosome function,” Trends in Cell Biology, vol. 18, no. 8, pp. 379–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. K. Jung, J. H. Jung, G. S. Park, A. Lee, C. S. Kang, and K. Y. Lee, “Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer,” Pathology International, vol. 56, no. 9, pp. 503–509, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. B. C. Parker, M. J. Annala, D. E. Cogdell et al., “The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma,” The Journal of Clinical Investigation, vol. 123, no. 2, pp. 855–865, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. I. H. Still, P. Vince, and J. K. Cowell, “The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines,” Genomics, vol. 58, no. 2, pp. 165–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Yao, Y. Natsume, Y. Saiki et al., “Disruption of Tacc3 function leads to in vivo tumor regression,” Oncogene, vol. 31, no. 2, pp. 135–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Bernard-Pierrot, A. Brams, C. Dunois-Larde et al., “Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b,” Carcinogenesis, vol. 27, no. 4, pp. 740–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Capelletti, M. E. Dodge, D. Ercan et al., “Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma,” Clinical Cancer Research, vol. 20, no. 24, pp. 6551–6558, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. B. A. Carneiro, J. A. Elvin, S. D. Kamath et al., “FGFR3-TACC3: a novel gene fusion in cervical cancer,” Gynecologic Oncology Reports, vol. 13, pp. 53–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Yuan, Z. H. Liu, Z. R. Lin, L. H. Xu, Q. Zhong, and M. S. Zeng, “Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma,” Cancer Biology & Therapy, vol. 15, no. 12, pp. 1613–1621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Li, H. Liu, C. Lai, X. Du, Z. Su, and S. Gao, “The Lin28/let-7a/c-Myc pathway plays a role in non-muscle invasive bladder cancer,” Cell and Tissue Research, vol. 354, no. 2, pp. 533–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. C. W. Yeh, S. S. Huang, R. P. Lee, and B. Y. Yung, “Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells,” Molecular Pharmacology, vol. 70, no. 4, pp. 1443–1453, 2006. View at Publisher · View at Google Scholar · View at Scopus